|
44
|
159
|
2ow1A |
Mmp-9 active site mutant with trifluoromethyl hydroxamate inhibitor |
|
43
|
158
|
2oxuA |
Uninhibited form of human mmp-12 |
|
40
|
159
|
2ovxA |
Mmp-9 active site mutant with barbiturate inhibitor |
|
41
|
159
|
2ovzA |
Mmp-9 active site mutant with phosphinate inhibitor |
|
43
|
156
|
2ow2A |
Mmp-9 active site mutant with difluoro butanoic acid inhibitor |
|
52
|
248
|
2mzhA |
Nmr solution structure of the pro form of human matrilysin (prommp-7) in complex with zwitterionic membrane |
|
42
|
164
|
2mlrA |
Membrane bilayer complex with matrix metalloproteinase-12 at its alpha-face |
|
44
|
164
|
2n8rA |
Productive complex between mmp-12 and synthetic triple-helical collagen, revealed through paramagnetic nmr |
|
16
|
165
|
2k2gA |
Solution structure of the wild-type catalytic domain of human matrix metalloproteinase 12 (mmp-12) in complex with a tight-binding inhibitor |
|
19
|
152
|
2krjA |
High-resolution solid-state nmr structure of a 17.6 kda protein |
|
13
|
152
|
2k9cA |
Paramagnetic shifts in solid-state nmr of proteins to elicit structural information |
|
35
|
106
|
2l0rA |
Conformational dynamics of the anthrax lethal factor catalytic center |
|
57
|
248
|
2mziA |
Nmr solution structure of the pro form of human matrilysin (prommp-7) in complex with anionic membrane |
|
38
|
164
|
2mlsA |
Membrane bilayer complex with matrix metalloproteinase-12 at its beta-face |
|
45
|
250
|
2mzeA |
Nmr solution structure of the pro form of human matrilysin (prommp-7) |
|
38
|
161
|
2jt6A |
Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of 3-4'-cyanobyphenyl-4-yloxy)-n-hdydroxypropionamide (mmp-3 inhibitor vii) |
|
32
|
160
|
2jsdA |
Solution structure of mmp20 complexed with nngh |
|
41
|
161
|
2jnpA |
Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-isobutyl-n-[4-methoxyphenylsulfonyl]glycyl hydroxamic acid (nngh) |
|
42
|
161
|
2jt5A |
Solution structure of matrix metalloproteinase 3 (mmp-3) in the presence of n-hydroxy-2-[n-(2-hydroxyethyl)biphenyl-4-sulfonamide] hydroxamic acid (mlc88) |
|
90
|
296
|
2jihA |
Crystal structure of human adamts-1 catalytic domain and cysteine- rich domain (complex-form) |
|
84
|
259
|
2j83A |
Ulilysin metalloprotease in complex with batimastat. |
|
43
|
161
|
2j0tA |
Crystal structure of the catalytic domain of mmp-1 in complex with the inhibitory domain of timp-1 |
|
42
|
158
|
2hu6A |
Crystal structure of human mmp-12 in complex with acetohydroxamic acid and a bicyclic inhibitor |
|
84
|
255
|
2i47A |
Crystal structure of catalytic domain of tace with inhibitor |
|
81
|
261
|
2fv5A |
Crystal structure of tace in complex with ik682 |
|
81
|
258
|
2fv9A |
Crystal structure of tace in complex with jmv 390-1 |
|
129
|
426
|
2eroA |
Crystal structure of vascular apoptosis-inducing protein-1(orthorhombic crystal form) |
|
121
|
426
|
2erpA |
Crystal structure of vascular apoptosis-inducing protein-1(inhibitor-bound form) |
|
130
|
424
|
2erqA |
Crystal structure of vascular apoptosis-inducing protein-1(tetragonal crystal form) |
|
126
|
414
|
2dw0A |
Crystal structure of vap2 from crotalus atrox venom (form 2-1 crystal) |
|
113
|
416
|
2e3xA |
Crystal structure of russell's viper venom metalloproteinase |
|
48
|
165
|
2e2dA |
Flexibility and variability of timp binding: x-ray structure of the complex between collagenase-3/mmp-13 and timp-2 |
|
118
|
415
|
2dw1A |
Crystal structure of vap2 from crotalus atrox venom (form 2-2 crystal) |
|
38
|
173
|
2ddyA |
Solution structure of matrilysin (mmp-7) complexed to constraint conformational sulfonamide inhibitor |
|
117
|
415
|
2dw2A |
Crystal structure of vap2 from crotalus atrox venom (form 2-5 crystal) |
|
82
|
257
|
2ddfA |
Crystal structure of tace in complex with tapi-2 |
|
50
|
171
|
2d1oA |
Stromelysin-1 (mmp-3) complexed to a hydroxamic acid inhibitor |
|
48
|
166
|
2d1nA |
Collagenase-3 (mmp-13) complexed to a hydroxamic acid inhibitor |
|
78
|
367
|
2cltA |
Crystal structure of the active form (full-length) of human fibroblast collagenase. |
|
82
|
262
|
2ckiA |
Structure of ulilysin, a member of the pappalysin family of metzincin metalloendopeptidases. |
|
71
|
201
|
2aigP |
Adamalysin ii with peptidomimetic inhibitor pol647 |
|
29
|
157
|
2aykA |
Inhibitor-free catalytic fragment of human fibroblast collagenase, nmr, minimized average structure |
|
263
|
750
|
1zxvA |
X-ray crystal structure of the anthrax lethal factor bound to a small molecule inhibitor, bi-mfm3, 3-{5-[5-(4-chloro-phenyl)-furan-2-ylmethylene]-4-oxo-2-thioxo-thiazolidin-3-yl}-propionic acid. |
|
46
|
165
|
1ztqA |
Crystal structure of the catalytic domain of mmp-13 complexed with way-033 |
|
87
|
259
|
1zxcA |
Crystal structure of catalytic domain of tnf-alpha converting enzyme (tace) with inhibitor |
|
47
|
163
|
1zs0A |
Crystal structure of the complex between mmp-8 and a phosphonate inhibitor (s-enantiomer) |
|
49
|
163
|
1zvxA |
Crystal structure of the complex between mmp-8 and a phosphonate inhibitor (r-enantiomer) |
|
84
|
259
|
2a8hA |
Crystal structure of catalytic domain of tace with thiomorpholine sulfonamide hydroxamate inhibitor |
|
51
|
163
|
1zp5A |
Crystal structure of the complex between mmp-8 and a n-hydroxyurea inhibitor |
|
270
|
696
|
1y8jA |
Crystal structure of human nep complexed with an imidazo[4,5-c]pyridine inhibitor |
